Auditory science company Cilcare has appointed veteran audiologist and biotech executive Kevin Franck, PhD, MBA, as head of the U.S. and general manager of North America to lead the company's regional growth and partnership strategies.
Hearing Health & Technology Matters has announced the winners of its seventh annual Hearing Technology Innovator Awards, with Oticon claiming the top honor for its Oticon Zeal hearing aid. The 2026 program recognizes groundbreaking technologies and services across multiple categories, highlighting advancements in hearing aids, implants, software, and clinical equipment.
Legato has launched its AI-powered hearing glasses in the US, combining FDA-regulated over-the-counter hearing technology with prescription-compatible eyewear to help bridge the gap in hearing care adoption.
Signia recently gathered hearing care professionals in Dallas to mark the U.S. launch of its new Multi-adaptive Xperience (MaX) platform, a multi-dimensional AI hearing aid technology designed to help wearers navigate complex group conversations in noise.
Read More
Elehear’s Beyond 2 Pro receiver-in-canal OTC hearing device features upgraded VocClear 3.0 sound processing, Auracast support, and integrated tele-audiology services.
Read More
EssilorLuxottica’s Nuance Audio Plus is the next generation of its FDA-cleared hearing glasses, featuring improved amplification, extended battery life, and hands-free phone calling for adults with mild-to-moderate hearing loss.
Read More
Auditdata has appointed Christoffer Spangenberg as its new CEO, succeeding Kurt Bager, effective September 25, 2026.
Read More
Sensorion has announced registration details for its upcoming SENS-601 Program Day on September 22, 2026, which will spotlight the science, patient population, and clinical trial design for its lead GJB2 gene therapy candidate. The event will feature key insights from company leadership and clinical experts regarding the HearConnex trial aimed at addressing hereditary hearing loss.
Read More
A new multicenter study demonstrates strong efficacy outcomes for cochlear implants in children as young as 7 months and those with residual hearing, adding clinical weight to calls for updated FDA candidacy criteria.
Read More
The France-based clinical-stage biotech, known for its pipeline of gene therapies targeting hearing loss, has confidentially submitted a draft registration statement to the SEC as it evaluates a potential listing on a US national exchange.
Read More
Canadian Hearing Services has awarded 28 scholarships to Deaf and hard of hearing post-secondary students across Canada for the 2026-2027 academic year.
Read More
Data from the Phase 2 STS-J01 trial presented at SIOP 2026 show that Fennec Pharmaceuticals’ Pedmark significantly reduced cisplatin-related hearing loss in pediatric and AYA patients in Japan while maintaining a high tumor response rate.
Read More
Amplifon has called a shareholders’ meeting to approve a capital increase advancing its acquisition of GN Hearing, a major consolidation move expected to close by late 2026.
Read More
Ampetronic and Listen Technologies’ Auracast-based Auri assistive listening system offers houses of worship an ADA-compliant, flexible audio accessibility solution to foster greater inclusion for congregants.
Read More
To truly understand a clinic’s performance, hearing care professionals must look beyond top-line revenue and use data to connect financial metrics with operational efficiency and patient outcomes.
Read More
WSA has appointed life sciences finance veteran Peter Bøggild as its new chief financial officer and member of the executive board.
Read More
The Naval Air Systems Command’s Aircrew Systems Program Office selected Aware Defense as its exclusive end-to-end provider of 3D-scanned, custom-fit hearing protection.
Read More
A new fMRI acquisition method developed at the University of North Carolina reduces peak scan noise from levels exceeding 120 decibels.
Read More